Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 12.00 (3.209%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss

Tue, 20th Apr 2021 12:08

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Zegona Communications PLC - acquires businesses in European telecommunications, media and technology sector - Posts pretax profit of EUR14.0 million in 2020, falling 67% from EUR42.1 million in 2019. Finance income plummets to EUR3.8 million from EUR38.2 million. "The principal reason for the movement compared to 2019 was that 2019 included a EUR28 million gain on the investment in Euskaltel and EUR10 million dividend from Euskaltel before it was accounted for as an associate," explains Zegona. Investee Euskaltel is a telecommunications provider in the North of Spain. Zegona to pay 4.6p per share to shareholders for 2020, down 8.0% from 5.0p for 2019. Zegona is the leading shareholder in Euskaltel and has two board seats. Euskaltel "expects significant further growth in 2021, both in terms of customer numbers and revenue".

----------

Aquila European Renewables Income Fund PLC - renewable energy infrastructure investor - Reports net asset value per share at December 31 of 99.96 euro cents, down 2.7% from 102.7 cents a year prior. Net assets double to EUR316.9 million from EUR158.9 million. Declares dividend of 4.0 cents per share for 2020, up from 1.5 cents for 2019 and in line with its dividend target of 4.0 cents. Aims to increase dividend target to 5.0 cents per share in 2021. Says its investment strategy is unchanged, and it will continue to invest in renewable energy projects in Europe and the UK. Notes continuing uncertainty caused by Covid-19.

----------

RBG Holdings PLC - London-based law firm - Post pretax profit for 2020 of GBP7.7 million, up 1.3% from GBP7.6 million the year prior. Revenue increases 13% to GBP22.4 million from GBP19.9 million. Personnel costs increase to GBP17.9 million from GBP11.5 million. Pays dividend of 3 pence per share for year. "Based on current outlook, we expect to pay up to 60 per cent of retained earnings in the 2021 financial year by way of dividend," says RBG. "The business will benefit from life post-Brexit and post-Covid as businesses return to normality. Our litigation finance business, LionFish is now established, and we expect the number of cases it invests in to grow, with the first return expected in the first half. With a strong pipeline of deals, and increased interest in [mergers & acquisitions] in 2021, Convex Capital is expected to perform well," says RBG. Convex Capital is a specialist provider of sell-side only M&A advice to UK, US and European entrepreneurs.

----------

Flowtech Fluidpower PLC - Cheshire, England-based valves and hydraulic components maker - Posts pretax loss for 2020 of GBP2.1 million, swinging from a GBP4.7 million profit a year prior. Revenue falls 15% to GBP95.1 million from GBP112.4 million. "With hindsight, there are areas that we could have improved on, particularly around the pace with which we have been able to extract cost from our order, pick and drop activities, that will be essential to our future success...However, we end 2020 having made progress in creating the platform that will ensure our future growth," says Flowtech. Does not declare dividend, but says it remains "keen to reintroduce a final payment for the financial year 2021, and thereafter adopt a balanced approach to dividend policy". "We have been encouraged by our performance over the past quarter, with both revenue and margins trending slightly above our expectations. The combination of Brexit and Covid-19, and in particular the current challenged nature of global supply chains, continue to make underlying trading difficult to interpret. What is clear is there has been a continued upward trend in our 'resellers' business, and evidence of restocking in our OEM customers," says Flowtech. Says if current trading continue, company could exit 2021 with similar revenue to 2019.

----------

MaxCyte Inc - Maryland-based cell and gene therapies firm - Posts net loss of USD11.8 million in 2020, narrowing 8.5% from USD12.9 million the year prior. Revenue increases 21% to USD26.2 million from USD21.6 million. Says it has never declared or paid common stock dividends and has no plans to do so in the foreseeable future. "We expect strong revenue growth in 2021, driven by the continuing progress of our existing strategic partners into and through the clinic and subsequent generation of increased milestone revenues. We are also confident that throughout the coming year we will continue to build our customer base and continue to secure further high-value licensing agreements, driving ongoing growth. The strategic partnership pipeline coming into 2021 is the largest that the company has experienced to date," says MaxCyte.

----------

discoverIE Group PLC - Guildford-based designer, manufacturer and supplier of customised electronics - Says trading momentum in the final two months of the year, to March 31, has continued to strengthen, and the company now expects underlying earnings for the full year to be above the upper end of market expectations. Says sales in the second half were 9% ahead of the first half with a return to organic growth of 1% in the last two months of the year. Sales for the full year were 3% lower, down 6% organically. "The strong order book and momentum provide a solid base for sustained organic sales growth whilst further investing in growth initiatives," says company.

----------

Filta Group Holdings PLC - AIM-listed provider of fryer management - Swings to pretax loss of GBP866,231 in 2020 from a GBP936,284 profit a year prior. Revenue falls 34% to GBP16.4 million from GBP24.9 million. Does not declare a final dividend, compared to 1.0p per share a year before. Says that "provided the progress that has been made in the first quarter of the year continues, it fully expects to be able to resume the payment of dividends in respect of 2021". Says that the upward trend in business levels that the company saw in the second half of 2020 has continued into the current year, with the numbers of new customers in both of its markets, the UK and North America, being particularly encouraging. "With the lockdown restrictions expected to be lifted further over the next two to three months and with the vaccination programmes progressing well in the UK and US, the board is confident that the progress that we have seen in the first quarter will continue through the year and, moreover, that the group is emerging from a highly challenging time much stronger operationally and in robust financial health," says Filta.

----------

IQ-AI Ltd - medical software company with headquarters in Jersey - Posts pretax loss for 2020 of GBP717,534, widening from GBP638,654 in 2019. Administrative expenses increase 5.4% to GBP933,462 from GBP885,757. Revenue falls 6.4% to GBP255,314 from GBP272,867. Declares no dividend for 2020, unchanged from 2019. Says the top priority going forward is to "increase in sales and distribution of its advanced imaging solutions".

----------

J Smart & Co (Contractors) PLC - Edinburgh-based construction contractor - Posts pretax profit for the first half to end-January of GBP890,000, widening from GBP265,000 a year before. Revenue falls 38% to GBP5.8 million from GBP9.3 million. Cost of sales halve to GBP5.3 million from GBP10.0 million. Announces an interim dividend of 0.95p per share, flat with the year prior. "We have substantially less work in hand in contracting than the same time last year. It is by no means certain that new contracting work will be secured this financial year due to general delays caused by the coronavirus pandemic," says J Smart. Says it is difficult to give accurate guidance due to uncertainties, but the company does not expect underlying profit to increase this financial year.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Mar 2023 15:54

UK earnings, trading statements calendar - next 7 days

Thursday 9 March 
Aviva PLCFull Year Results
ConvaTec Group PLCFull Year Results
Digital 9 Infrastructure PLCFull Year Results
Domino's Pizza Group PLCFull Year Results
DS Smith PLCTrading Statement
Endeavour Mining PLCFull Year Results
Entain PLCFull Year Results
Forterra PLCFull Year Results
Franchise Brands PLCFull Year Results
Hammerson PLCFull Year Results
Harbour Energy PLCFull Year Results
Hansard Global PLCHalf Year Results
Headlam Group PLCFull Year Results
Informa PLCFull Year Results
Kier Group PLCHalf Year Results
M&G PLCFull Year Results
Network International Holdings PLCFull Year Results
Oakley Capital Investments LtdFull Year Results
PageGroup PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Spirax-Sarco Engineering PLCFull Year Results
Volution Group PLCHalf Year Results
Wheaton Precious Metals CorpFull Year Results
Friday 10 March 
Allianz Technology Trust PLCFull Year Results
Berkeley Group HoldingsTrading Statement
BP PLCFull Year Results
FBD Holdings PLCFull Year Results
Lancashire Holdings LtdFull Year Results
Mineral & Financial Investments LtdHalf Year Results
Robert Walters PLCFull Year Results
Monday 13 March 
Direct Line Insurance Group PLCFull Year Results
Fonix Mobile PLCHalf Year Results
HgCapital Trust PLCFull Year Results
MTI Wireless Edge LtdFull Year Results
Nightcap PLCHalf Year Results
Phoenix Group Holdings PLCFull Year Results
Stelrad Group PLCFull Year Results
Tuesday 14 March 
Aptamer Group PLCHalf Year Results
Close Brothers Group PLCHalf Year Results
Costain Group PLCFull Year Results
Eagle Eye Solutions Group PLCHalf Year Results
Genuit Group PLCFull Year Results
Gresham Technologies PLCFull Year Results
H&T Group PLCFull Year Results
Harworth Group PLCFull Year Results
Litigation Capital Management LtdHalf Year Results
Midwich Group PLCFull Year Results
Old Mutual LtdFull Year Results
PCI-PAL PLCHalf Year Results
Pennon Group PLCTrading Statement
Sabre Insurance Group PLCFull Year Results
Smart Metering Systems PLCFull Year Results
TP ICAP Group PLCFull Year Results
Virgin Wines UK PLCHalf Year Results
Yu Group PLCFull Year Results
Wednesday 15 March 
4imprint Group PLCFull Year Results
Advanced Medical Solutions Group PLCFull Year Results
Balfour Beatty PLCFull Year Results
Centaur Media PLCFull Year Results
FDM Group Holdings PLCFull Year Results
Ferrexpo PLCFull Year Results
Foresight Solar Fund LtdFull Year Results
IG Group Holdings PLCQ3 Results
Keywords Studios PLCFull Year Results
Kin & Carta PLCHalf Year Results
Marshalls PLCFull Year Results
MaxCyte IncFull Year Results
Prudential PLCFull Year Results
Trainline PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
7 Mar 2023 10:51

MaxCyte revenue grows in 2022, expects further revenue climb in 2023

(Alliance News) - MaxCyte Inc on Tuesday announced a higher revenue for 2022, and said it anticipates revenue to grow further during 2023.

Read more
7 Mar 2023 09:32

MaxCyte flags 2022 revenue growth, sets new guidance

(Sharecast News) - Cell engineering technology company MaxCyte said in an update on Tuesday that it was expecting full-year 2022 total revenue of $44.3m, which would represent growth of 31% over 2021.

Read more
30 Jan 2023 16:23

TRADING UPDATES: DP Eurasia annual sales grow despite Russia decline

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
4 Jan 2023 08:56

MaxCyte signs strategic platform licence with Catamaran Bio

(Alliance News) - MaxCyte Inc on Wednesday said it signed a strategic platform licence with biotechnology company Catamaran Bio Inc.

Read more
4 Jan 2023 07:45

MaxCyte signs strategic platform licence with Catamaran Bio

(Sharecast News) - Commercial cell engineering company MaxCyte announced the signing of a strategic platform licence (SPL) with Catamaran Bio on Wednesday.

Read more
5 Dec 2022 21:49

TRADING UPDATES: MaxCyte in deal; Angus to resume Saltfleetby drilling

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2022 13:28

MaxCyte inks deal with South Korea's Curamys

(Sharecast News) - Cell engineering technology company MaxCyte announced a strategic platform licence with South Korea-based biotechnology specialist Curamys on Monday, which develops cell and gene therapies using cell fusion technology to treat rare intractable diseases, including Duchenne muscular dystrophy and amyotrophic lateral sclerosis.

Read more
10 Nov 2022 13:06

MaxCyte revenues improve in third quarter

(Sharecast News) - Cell engineering technology specialist MaxCyte reported total third-quarter revenue of $10.6m on Thursday, making for an increase of 5% year-on-year.

Read more
2 Nov 2022 15:43

UK earnings, trading statements calendar - next 7 days

Thursday 3 November 
BT Group PLCHalf Year Results
Gattaca PLCFull Year Results
Glanbia PLCQ3 Results
Helios Towers PLCQ3 Results
Hikma Pharmaceuticals PLCTrading Statement
Howden Joinery Group PLCTrading Statement
J Sainsbury PLCHalf Year Results
Lancashire Holdings LtdTrading Statement
OSB Group PLCTrading Statement
Polymetal International PLCQ3 Results
RS Group PLCHalf Year Results
Rolls-Royce Holdings PLCTrading Statement
Smith & Nephew PLCTrading Statement
TI Fluid Systems PLCTrading Statement
Trainline PLCHalf Year Results
UP Global Sourcing Holdings PLCFull Year Results
WAG Payment Solutions PLCTrading Statement
Wheaton Precious Metals CorpQ3 Results
Woolworths Group LtdQ1 Results
Friday 4 November 
Apax Global Alpha LtdFull Year Results
Monday 7 November 
Great Eastern Energy Corp LtdHalf Year Results
Kingspan Group PLCTrading Statement
Ryanair Holdings PLCHalf Year Results
Tuesday 8 November 
Argentex Group PLCHalf Year Results
Associated British Foods PLCFull Year Results
Aveva Group PLCHalf Year Results
Beximco Pharmaceuticals LtdFull Year Results
Coca-Cola HBC AGTrading Statement
DCC PLCHalf Year Results
Direct Line Insurance Group PLCTrading Statement
Egdon Resources PLCFull Year Results
Hilton Food Group PLCTrading Statement
Marks Electrical Group PLCHalf Year Results
Oxford Instruments PLCHalf Year Results
Persimmon PLCTrading Statement
Warehouse REIT PLCHalf Year Results
YouGov PLCFull Year Results
Zoo Digital Group PLCHalf Year Results
Wednesday 9 November 
Aviva PLCTrading Statement
Biffa PLCHalf Year Results
Conduit Holdings LtdTrading Statement
Dignity PLCTrading Statement
Flutter Entertainment PLCTrading Statement
Gelion PLCFull Year Results
Georgia Capital PLCQ3 Results
Gym Group PLCTrading Statement
JD Wetherspoon PLCTrading Statement
ITV PLCTrading Statement
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Norcros PLCHalf Year Results
Picton Property Income LtdHalf Year Results
Smiths News PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Tracsis PLCFull Year Results
Volex PLCHalf Year Results
Watches of Switzerland Group PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Sep 2022 21:38

TRADING UPDATES: LoopUp, Surface raise capital; MaxCyte wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
11 Aug 2022 14:31

MaxCyte hikes guidance after solid first half

(Sharecast News) - Cell engineering company MaxCyte reported total first-half revenue of $21.2m on Thursday, up 56% year-on-year, as it increased its guidance for the full year.

Read more
10 Aug 2022 22:01

IN BRIEF: MaxCyte grows revenue but widens loss in second quarter

MaxCyte Inc - Gaithersburg, Maryland-based platform for cell-based research - Says second quarter revenue grew 35% year-on-year to USD9.6 million from USD7.1 million, "driven by strong growth in the cell therapy market; core business revenues grew 45% led by revenue from cell therapy customers which increased 61%, with drug discovery revenues growing by 4%", the firm says. Net loss for the quarter widens to USD8.3 million from US4.4 million. For the first half as a whole, revenue rises 56% year-on-year to USD21.2 million from USD13.6 million, as net loss widens slightly to USD12.3 million from USD11.5 million. Expects core business revenue in full year to grow approximately 30%. Continues to expect SPL Program-related revenue to be around USD4 million for the year. Says is making investments to drive revenue growth, and expand applications for its technology.

Read more
3 Aug 2022 15:57

UK earnings, trading statements calendar - next 7 days

Thursday 4 August 
  
Centamin PLCHalf Year Results
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Informa PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Friday 5 August 
FBD Holdings PLCHalf Year Results
Hargreaves Lansdown PLCFull Year Results
London Stock Exchange Group PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewables Infrastructure Group LtdHalf Year Results
WPP PLCHalf Year Results
Monday 8 August 
Clarkson PLCHalf Year Results
Diversified Energy Company PLCHalf Year Results
Gran Tierra Energy IncQ2 Results
Griffin Mining LtdHalf Year Results
ITM Power PLCFull Year Results
Kosmos Energy LtdQ2 Results
PageGroup PLCHalf Year Results
RM Infrastructure Income PLCHalf Year Results
Tuesday 9 August 
abrdn PLCHalf Year Results
Bellway PLCTrading Statement
Blue Planet Investment Trust PLCFull Year Results
Burford Capital LtdHalf Year Results
Clarkson PLCHalf Year Results
H&T Group PLCHalf Year Results
InterContinental Hotels Group PLCHalf Year Results
IWG PLCHalf Year Results
Just Group PLCHalf Year Results
Legal & General Group PLCHalf Year Results
Quarto Group IncHalf Year Results
RPS Group PLCHalf Year Results
SIG PLCHalf Year Results
TI Fluid Systems PLCHalf Year Results
Zotefoams PLCHalf Year Results
Wednesday 10 August 
4imprint Group PLCHalf Year Results
Aberdeen New India Investment Trust PLCFull Year Results
Admiral Group PLCHalf Year Results
Arix Bioscience PLCHalf Year Results
Atalaya Mining PLCHalf Year Results
Avast PLCHalf Year Results
Aviva PLCHalf Year Results
Baillie Gifford US Growth Trust PLCFull Year Results
BlackRock Energy & Resources Income Trust PLCHalf Year Results
CLS Holdings PLCHalf Year Results
Computacenter PLCTrading Statement
ContourGlobal PLCHalf Year Results
Deliveroo PLCHalf Year Results
Goodwin PLCFull Year Results
Henderson Smaller Cos Investment Trust PLCFull Year Results
Hostelworld Group PLCHalf Year Results
HydrogenOne Capital Growth PLCHalf Year Results
MaxCyte IncQ2 Results
Provident Financial PLCHalf Year Results
Prudential PLCHalf Year Results
Quilter PLCHalf Year Results
S&U PLCTrading Statement
TP ICAP Group PLCHalf Year Results
UK Commercial Property REIT LtdTrading Statement
Videndum PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 Jul 2022 14:05

IN BRIEF: MaxCyte enters strategic platform license agreement with LG

MaxCyte Inc - Gaithersburg, Maryland-based platform for cell-based research - Signs a strategic platform license agreement with Korean chemical company LG Chem Ltd, a subsidiary of LG Corp. Explains that the deal gives LG non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform. MaxCyte will receive platform licensing fees and programme related revenue.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.